Please do not queue at limit up... gradual increase reflective of company’s value... otherwise alot of speculators may take advantage.. once we invest, we hold...

companies such as jp morgan makes their quick gain through short selling companies, aided by their manipulation of markets through media and their investment reports to their advantage... they will do this again and again... yet they are not reprimanded by Securities Commission...
i, for once am truly happy the little guy on the street fights back and hopefully win....

i will hold my shares till they cover their shorts and leave...

Do kindly be informed that analyst are also normal human being (like you and me) working for the company’s interest...
otherwise they are millionaires/ billionaires...
trust your decision and be firm.. short sellers manipulate by selling high and buying low... as long as they make make their margin and covers their cost of capital.. its purely business..

Hence, even if i place a discount (due to pandemic) and premium (due to its global leader advantage) i think Top Glove is severely undervalued by up to 50%

In M&A (mergers & acquisition), the desktop research (before technical, financial and commercial due diligence) in evaluation of company is based on EBITDA per annum multiples and for healthcare are typically 12 - 20. And these companies are only willing to sell as they are not doing well and there is value for the buyer in acquisition. Top Glove rm 9 bln indicate a typical value of between rm 108 bln - 120bln.

top glove current market capitalization is approximately 54bln RM. Lets say you buy the company at 54bln RM with cash. at estimated 9bln RM profit per annum, the simple IRR (investment rate of return) is 6 years. and after that you own a global business at which continues to generate profitable income...

all over the world, indicate severe shortage of gloves for healthcare workers...
do not allow manipulation of other to affect your investment decision..
it is easy to write bias articles, recommendations, hence trust is current real data... ( i.e increasing demand, expansion of facility, net cash position, digitalization, strong dividend policy, positive outlook, advantage of market leader, etc)

key aim for short sellers is to buy back all shares before the next financial quater which will be another record where the result will beat analyst expectations, hence the uptrend...
so risk is lower during current period to manipulate top glove share price...

https://www.google.com/amp/s/www.walesonline.co.uk/news/wales-news/coronavirus-covid-vaccine-strain-africa-19557838.amp

https://www.google.com/amp/s/www.dailymail.co.uk/news/article-9109397/amp/South-African-coronavirus-mutation-BEAT-current-vaccines.html

https://www.google.com/amp/s/www.wionews.com/world/mexican-doctor-admitted-to-icu-after-receiving-pfizer-covid-19-vaccine-354093/amp

https://uk.reuters.com/article/us-malaysia-top-glove-breakingviews/breakingviews-rubber-glove-selloff-gets-out-of-hand-idUKKBN28Q0BD

The remedy for the falling Mercator Medical prices will be the share buyback, which will begin today. The board also commented on the theses contained in JP Morgan’s report, which managed to beat the rate yesterday.

The board of directors called conferences for today (they will take place at 11 a.m., we will report them on pb.pl) and also published a report on the start of the share buyback.

The buyback starts on December 15 and lasts until June 3, 2021 unless the buyback pool is exhausted earlier.

According to the resolution of the general meeting, the company can buy back PLN 803 thousand. Shares (7.6% of the capital) for a maximum of PLN 20 million.

At the current rate (342 PLN at the end of the session on Monday) the company was able to achieve approx. Yesterday the volume was 483 thousand. Pieces, and sales of PLN 176 million.

Last week, Mercator Medical’s holdings, which grew rapidly in response to the pandemic demand for the company’s protective gloves, were weakened by the president’s sale of a significant block of shares. The moment to sell turned out to be good as all the major glove manufacturers are falling this week.

On Monday, following the release of JP Morgan’s skeptical report on Malaysian glove manufacturers, quotes fell 15 percent. Mercator’s board of directors responded by organizing a conference call.

– Despite what you can read in the JP Morgan report, we believe we are in what is known as prime time for the industry. We believe that prices and margins will be very satisfactory next year, which can be used in favor of Mercator – says Wiesław Żyznowski, President and main shareholder of Mercator.

JP Morgan analysts believed that “the extraordinary phase of the industry cycle is over” and that the glove manufacturers’ increase in production capacity, which will reach nearly 90% in the next three to five years, will be reflected in the hiccups

– Of course, the increase in production capacity in the world is a fact and we are working on it ourselves. However, it is difficult to say when falling demand will overlap with growing supply. It is estimated that this will happen in mid-2022. However, we believe that we will be immune to this as we will mainly be making specialty gloves that are subject to slightly different rules. We will of course be able to produce mainstream gloves if it pays off – says Wiesław Żyznowski.

was forecasting qtr PAT of 70-80 mln... very nice surprise indeed...

Something to think about: Kathrin Jansen, a senior vice president and the head of vaccine research and development at Pfizer - that she learned of the results on Sunday just after 1pm ..... vaccine phase 3 preliminary information was announced on Monday... CEO Pfizer sold US5.66 mln on Monday and also Pfizer Senior Management.... A Pfizer spokesperson said of CEO Pfizer stock sale, the sale was part of a predetermined plan created in August....

Note: it may be a coincidence

https://app2.msci.com/eqb/gimi/smallcap/MSCI_Nov20_SCPublicList.pdf

Fyi, Comfort is added into MSCI small cap indexes list. In summary it is a recognition to Comfort as MSCI select stocks that have high liquidity and represents the underlying equity market well. Funds / Investment Firms / Investors evaluate MSCI stocks in weighting of small cap stocks as part of diversified investment portfolio as it provide exposure which offer faster growth, good risk-adjusted returns which has different virtues with larger cap stocks. Hope this helps.

Next QR | Est. Ann. Date: 31-Oct-2020 | 16-Dec-2020

It is based on historical announcement date. Upside from next QR: positive net cash flow... :)

sorry... typo... announcement of vaccine pre-trial limited findings

https://www.axios.com/pfizer-ceo-albert-bourla-stock-sale-covid-vaccine-c380a500-ee02-4106-befe-88b08c656d39.html

it shows the CEO foresee, risks in potential upside hence a stock sale during the announcement of Covid. Please evaluate and think for yourself and not allow emotions run high. If you are holding glove, dont invest with emotions.

https://www.bloomberg.com/news/articles/2020-11-10/brazil-pauses-trial-of-china-vaccine-after-serious-adverse-event

@axe... yeah... help to calm them down through data

https://www.healthnewsreview.org/2020/11/transparency-by-drug-companies-scrutiny-by-journalists-vital-in-vaccine-news/

please read ya... as a CEO, i will of course trumpet success in advance

please trust the data.... right now, pfizer has no data to back up their research... market react to it on the basis of a news release by a CEO and not a medical research report which must be peer reviewed...

pfizer researchers have not yet conducted an analysis of the efficacy of the vaccine it is developing against Covid-19....

to even distribute vaccine is a huge logistic problem (if its approved) -78deg C storage

not peer reviewed... no data showed...
announcement by news and not medical research...

jolow:... no announcement today... i think you had mistaken the date

i own maybank trading account.
No such research report on Top Glove. Latest is Kossan (TP: 19.50)and Comfort(TP: 4.80)

https://www.dailymail.co.uk/news/article-8654045/Scotland-sees-highest-rise-Covid-infections-three-months-123-new-cases.html

Hi Yttihs, please could you add me? Tqvm
I own top glove shares

I guess everyone at glove counters...

i think the net profit is around RM50 mln for Q2 2020...

Price down from 2.30... why??

Anyone heard of “the jv”? When would it be happening? Thks